NanoViricides Inc. (NNVC)

[NNVClover]

Common knowledge. Your own papers discuss how fringe it is to use mice in antiviral drug development. Every paper discusses past limitations to said use. Use your head and conclude that it's not the common practice. Take a look at any drug's development history. AZT, Isentress, lamivudine, etc - they all skipped mice because they're worthless preclinically (at least in this disease).

My sense is you haven't been in antiviral drug development. I've financed companies like ACHN and am well versed on this subject. A few papers can be found on any topic imaginable. Common practice is common practice.